← Back to Clinical Trials
Recruiting NCT07371962

NCT07371962 Sound Bite-- a Therapeutic Song-writing Program

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07371962
Status Recruiting
Phase
Sponsor City University of Hong Kong
Condition Depression
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2026-07-17
Primary Completion 2027-08-31

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 24 Years
Study Type INTERVENTIONAL
Interventions
therapeutic song-writing programWaitlist control group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2026-07-17 with a primary completion date of 2027-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The research aims to investigate the effectiveness of the therapeutic song-writing program on young people with depressive symptoms. This study adopts a multicentre randomized control trial two arms research design. A randomised controlled trial will compare a typical 7-session therapeutic song-writing program with a waitlist-control group to determine whether the 7-session therapeutic song-writing program can produce better outcomes for young people with depressive symptoms, including improvement in depressive symptoms, self-stigma, self-esteem, sense of hope and social support at post-intervention. The 7-session therapeutic song-writing program will be delivered by trained and experienced social workers and helping professionals who are familiar with music therapy. A research staff, who does not involve in the group allocation and delivery of group intervention, conduct the intervention outcomes assessment of the participants before and after the intervention. Standardized assessment tools are used to assess the intervention outcomes. The ethical considerations of this study were reviewed and approved by the Human and Artefacts Ethics Sub-Committee of the City University of Hong Kong in 2025.

Eligibility Criteria

Inclusion Criteria: 1. aged between 13 to 24 years; 2. having mild to moderate depression and/or anxiety as assessed using a standardized assessment tool, i.e. Chinese Depression Anxiety Stress Scale-Youth (DASS-Y) with a DASS-Y Depression score between 5 and 12; 3. service users of The Salvation Army social service unit; and 4. giving informed consent to this research work. For those aged below 18, parental consent will be obtained. Exclusion Criteria: Those with severe depression (i.e. a DASS-Y Depression score ≥ 13) and/or severe anxiety (i.e. a DASS-Y Anxiety score ≥ 8) are excluded from this study.

Contact & Investigator

Central Contact

Kim-wan Daniel Young, PhD

✉ dkwyoung@cityu.edu.hk

📞 +85234428954

Frequently Asked Questions

Who can join the NCT07371962 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 24 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07371962 currently recruiting?

Yes, NCT07371962 is actively recruiting participants. Contact the research team at dkwyoung@cityu.edu.hk for enrollment information.

Where is the NCT07371962 trial being conducted?

This trial is being conducted at Kowloon Tong, Hong Kong.

Who is sponsoring the NCT07371962 clinical trial?

NCT07371962 is sponsored by City University of Hong Kong. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology